BMT Adverse Reactions/Management Flashcards
(29 cards)
Hemorrhagic cystitis
inflammatory condition of urinary bladder with sudden onset of hematuria, bladder pain, irritative bladder symptoms
Hemorrhagic cystitis management with Cytoxan (4)
- Hyperhydration - TO BE STARTED NIGHT BEFORE CYTOXAN IS ADMINISTERED and again 6-12h post infusion
- Monitor UAs specific gravity (need SG to be <1.010 to start Cytoxan, if >1.010 then give 10cc/kg bolus NS)
- MESNA- to be given with high dose Cytoxan, acts to neutralize acrolein
- Ensure voiding q2h x 24h after Cytoxan admin (may require foley catheter or bladder irrigation)
Hyperhydration with Cytoxan/hemorrhagic cystitis
125mL/m2/hr of D5NS or D5 1/2 NS
SIADH
Syndrome of inappropriate anti-diuretic hormone; causes hyponatremia (though urine Na is high) and decreased bladder output (low sodium and low urine output)
SIADH treatment
Lasix & fluid restrictions
SIADH Prevention (6)
- strict Is&Os
- monitor specific gravity/UAs
- daily weights
- PRN lasix
- NS boluses
- Chem10 - monitor Na
Cardiotoxicity with Cytoxan prophylaxis
Order EKG prior to each dose and look for early evidence of decreased QRS voltage or T wave changes which may indicate early cardiotoxicity
Busulfan and hepatotoxicity (4: risk factors, management, ppx, treatment)
- Risk factors: Fe overload, abnormal LFTs, previous chemo, previous abdominal radiotherapy
- Monitor: weight, LFTs, I&Os, abd circumference, liver size
- Prophylaxis: Ursodiol/Actigall
- Treatment: defibrotide to treat VOD
Busulfan seizure ppx
Anti-convulsant, usually Ativan, give during Bu administration and 48h after; if it is a sickle cell patient, use Keppra (30mg/kg)
Thiotepa and skin changes management (3)
- Frequent baths by RN
- Minimal dressings and wear loose clothing
- Protective gear
PRES (posterior reversible encephalopathy syndrome)
CAUTION WITH TACROLIMUS LEVELS >15 1. Headache 2. HTN*** (give hydralazine) 3. Vision changes 4. Changes in mental status 5. Seiures If concerns - stop IV or PO med
Emergency meds to have at bedside on day 0
- Tylenol
- Benadryl
- Hydrocort - do not use with CAR-T or haplo
- Lasix
- Epinepherine
- Albuterol
- Hydralazine
Day 0 pearls if s/e (5)
- If patient has any type of reaction, stop infusion and then restart at slower rate
- If hypertension –> pause infusion; suspect fluid overload then give Lasix. If need immediate relief or BP not lowering, give hydralazine –> restart at 1/2 rate
- If coughing –> check for wheezing, pause, give albuterol, then once resolved restart at slower rate
- If hives –> Benadryl –> hydrocort if not resolving
- Complaints of itchy throat/closing –> epinepherine
VOD
When the small blood vessels that lead to or are inside the liver become damaged or blocked
Increased risk with busulfan, TBI and other chemo agents b/c they damage the endothelial cells (can act on CD33 expressed by liver cells)
VOD pathophysiology (5 steps)
1st: Damage to endothelium
2nd: Leakage
3rd: Clot formation (activation of coagulation cascade by leakage)
4th: Clot of bile ducts
5th: Reversal of flow, pain, ascites (fluid collected in abd)
S/S of VOD (6)
Hepatosplenomegaly, ascites, weight gain, increased bilirubin, jaundice
Labs with VOD (3)
- Elevated D dimer
- Elevated bili
- Low platelets
Diagnosis of VOD
Abdominal u/s with doppler to assess for reversal of flow
Diagnostic criteria of VOD (Seattle criteria, 3)
Presentation by day 20 post HSCT of at least two of the following:
- Bili > 2mg/dL
- Hepatomegaly or RUQ pain
- Weight gain >2%
Treatment of VOD
DEFIBROTIDE 6.25mg/kg IV q6 (antithrombotic that breaks up clots) & give concentrated IVF
BK Virus
A common virus that may become reactivated after transplant; can be in blood, bladder/kidney
May cause UTI type symptoms or hemorrhagic cystitis
Treatment for BK virus (4)
- If hemorrhagic cystitis: keep plt >50
- If pain: Pyridium x 3 days and ditropan indefinitely (Bladder relaxant)
- Hyperhydration to dilute RBCs and avoid clots
- For mild or refractory illness: cidofovir IV weekly (dose higher if refractory)
GVHD
When the donor’s cells attack the recipient’s body
acute: <100 days from transplant
chronic: >100 days from transplant
GVHD Treatment
Methylpred 2mg/kg IV
2nd line: jakafi